Next Generation Therapeutics, Inc.

Plymouth, MI 48170

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $335K
First Award Date 04/27/07
Most Recent Award Date 09/01/07

Key Personnel

Last Name Name Awards Contact
Reddy G R Reddy 2

2 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-09
Budget: 09/01/07 - 08/31/09
PI: G R Reddy

DESCRIPTION (provided by applicant): Although surgery and radiation are typically used in the treatment of malignant gliomas, the prognosis and 5-year survival rate for these patents is very poor. Gliomas are typically radioresistant and represent one of the most difficult tumors to treat by noninvasive methods. Gemcitabine is a potent radiosens...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-09
Budget: 04/27/07 - 08/31/07
PI: G R Reddy

DESCRIPTION (provided by applicant): Although surgery and radiation are typically used in the treatment of malignant gliomas, the prognosis and 5-year survival rate for these patents is very poor. Gliomas are typically radioresistant and represent one of the most difficult tumors to treat by noninvasive methods. Gemcitabine is a potent radiosens...